Incyte joins S&P 500
March 1, 2017
Incyte, the Delaware-based pharmaceutical research firm, has joined the S&P 500 Index. The index includes the most-owned stocks on the New York Stock Exchange and Nasdaq, the two largest exchanges […]
chat_bubble0 Comment
visibility1504 Views
Premier Digital Partners
© 2024 Delaware Business Times
